Discover a study that assessed the risk of hospitalisation for serious infections based on different categories of systemic ...

Plaque psoriasis is the most common type of psoriasis ... It’s usually triggered by infections, particularly strep throat. It doesn’t usually appear on the feet. Erythrodermic psoriasis ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

About Plaque Psoriasis Plaque psoriasis is a chronic ... ILUMYA may increase the risk of infection. Treatment with ILUMYA should not be initiated in patients with a clinically important active ...

Zay Nyi Nyi/Shutterstock Share on Pinterest Tinea capitis is a fungal infection on the scalp. Photography courtesy of Grook Da Oger/Wikimedia About half of all people with plaque psoriasis will ...

Ilumya is used to treat mild to severe plaque psoriasis. If this condition affects ... If you develop symptoms of an infection while having Ilumya treatment, see your doctor.

All patients treated with icotrokinra had plaque psoriasis for 26 weeks or more ... and upper respiratory tract infection (7% in both groups). According to the presentation, these adverse events ...

It is approved for use in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical ...

While nearly 8 million Americans live with plaque psoriasis, its impact is often unseen or covered up. 1 Art, whose music has touched millions worldwide, lived silently with his psoriasis—until now.